JUN 8, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Labetalol Hydrochloride (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of labeling changes for labetalol hydrochloride tablets; does not contain clinical trial data or efficacy evidence.
Reported
Approval date2026-06-08
Application numberANDA212990